Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets;Vergleich der resorption von oral als granulat oder tabletten verabreichtem lornoxicam bei gesunden probanden

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 6, 1997, Pages 755-757

  Bareggi, Silvio R ^a,c   Gambaro, Veniero ^b,c   Valenti, Mauro ^a,c   Benvenuti, Claudio ^b,c  

^a Medical School   (Italy)

^b School of Pharmacy   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Analgesics; Anti inflammatories; CAS 70374 39 9; Lornoxicam, bioavailability, clinical studies

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; LORNOXICAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG GRANULE; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TABLET;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; MICROSPHERES; MIDDLE AGED; PIROXICAM; TABLETS;

EID: 0030789517     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Pruss, T. P., Stroissing, H., Radhofer-Welte, S. et al., Postgrad. Med. J. (Suppl. 4), S18 (1990)
2. Gomeni, C, Gomeni, R., Comp. Biom. Res. 11, 345 (1978)
3. Westlake, W. J., in: Biopharmaceutical statistics for drug development, K. E. Peace (ed.), pp. 329-352, Marcel Dekker, New York (1988)
4. Schuirmann, D. J., J. Pharmacokin. Biopharm. 15, 657 (1987)
5. Ankier, S. I., Brimelow, A. E., Crome, P. et al., Postgrad. Med. J. 64, 752 (1988)
6. Olkkola, K. T., Brunetto, A. V., Mattila, M. J., Clin. Pharmacokin. 26, 106 (1994)